Market Herald logo

Subscribe

Be the first with the news that moves the market

Cardiol Therapeutics (TSX:CRDL): The clinical-stage life sciences company that’s developing CBD-based treatments for cardiovascular diseases

It can be hard to wrap your head around the number of diseases and conditions people live with every day, but almost everyone knows someone who is affected by heart disease. Around 73,000 people in the U.S. live with acute myocarditis, and approximately 38,000 live with recurrent pericarditis. Still, several intriguing medical plays are advancing unique treatments, and one among those that is clearly ahead of the pack.

The Market Herald Canada’s Jon Brown reports on a company making a real difference in combating this sometimes-lethal heart condition.

Read the Full Story Here

Weekly Update – Top Cannabis News Stories

1 | Top Story: HEXO (TSX:HEXO) and Tilray (TSX:TLRY) complete transaction, building an alliance between two cannabis giants.

2 | High Tide Inc. (TSXV:HITI) opens first Canna Cabana location in British Columbia.

3 | Terranueva Corp. (CSE :TEQ) closes $2.9 million private placement.

4 | MediPharm Labs Corp. (TSX:LABS) sells Australian subsidiary.

5 | Fire & Flower Holdings Corp. (TSX:FAF) and Pineapple Express launch recreational cannabis delivery in B.C.

Top Cannabis Stocks July 7 to July 13, 2022

1. T.WEED | 15,764 views | Canopy Growth Corp.
2. T.HEXO |11,886 views | HEXO Corp.
3. TLRY | 7,271 views | Tilray Brands Inc.
4. C.TNY | 3,867 views | Tinley Beverage Co Inc.
5. T.TBP | 3,444 views | Tetra Bio-Pharma Inc.
6. C.OILS | 2,563 views | Nextleaf Solutions Ltd .

New to investing in Cannabis? Check out Stockhouse tips on How to Invest in Cannabis Stocks and some of our Top Cannabis Stocks.

For more of the latest info on Cannabis, check out the Cannabis Trending News hub. Or, for lively sector discussion, visit Stockhouse’s new Cannabis Bullboards page.

More From The Market Herald

" Miners highlight the role of commodities in your portfolio

As supply chain constraints linger across the globe, prospective commodity allocations are front and centre.

" @ the Bell: Markets retreat at the end of the week

Canada’s main stock index posted a triple digit decline by Friday’s close thanks to losses in the technology and base metal sectors.
Emerald Health Therapeutics Inc. - Director & Chairman, Jim Heppell.

" Emerald Health (CSE:EMH) shareholders approve merger

Emerald Health Therapeutics (EMH), has received shareholders’ approval for the proposed plan of arrangement with Skye Bioscience Inc.

" Lobe Sciences (CSE: LOBE) update psilocin compounds and development plans on site

Lobe Sciences (LOBE) is updating its corporate presentation describing plans for advancing the development of its psilocin analogues L-130 and L-131.